Brief: Tscan Therapeutics Announces Pricing Of Upsized $150 Mln Public Offering
17/04/2024 05:32
April 17 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $150
MILLION
PUBLIC OFFERING
* TSCAN THERAPEUTICS INC - UNDERWRITTEN PUBLIC OFFERING OF
2.5
MILLION SHARES OF ITS VOTING COMMON STOCK AT A PUBLIC OFFERING
PRICE OF $7.13 PER SHARE
Source text for Eikon: ID:nGNX7CpjFN
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing